Related Experiment Video
Updated: Jun 26, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor
Carlos J P Alvarez1, María Lodeiro, Marily Theodoropoulou
1Laboratorio de Endocrinología Molecular y Celular, Instituto de Investigaciones Sanitarias, Complejo Hospitalario Universitario de Santiago (CHUS), 15706 Santiago de Compostela, Spain.
Abstract:
Obestatin was identified as a gut peptide encoded by the ghrelin gene that interacts with the G protein-coupled receptor, GPR39. In this work, a sequential analysis of its transmembrane signalling pathway has been undertaken to characterize the intracellular mechanisms responsible for Akt activation. The results show that Akt activation requires the phosphorylation of T308 in the A-loop by the phosphoinositide-dependent kinase 1 (PDK1) and S473 within the HM by the mammalian target of rapamycin (mTOR) kinase complex 2 (mTORC2: Rictor, mLST8, mSin1, mTOR kinase) with participation neither of G(i)(/o)-protein nor Gbetagamma dimers. Obestatin induces the association of GPR39/beta-arrestin 1/Src signalling complex resulting in the transactivation of the epidermal growth factor receptor (EGFR) and downstream Akt signalling. Upon administration of obestatin, phosphorylation of mTOR (S2448) and p70S6K1 (T389) rise with a time course that parallels that of Akt activation. Based on the experimental data obtained, a signalling pathway involving a beta-arrestin 1 scaffolding complex and EGFR to activate Akt signalling is proposed.
Insights
Obestatin activates Akt signaling through a novel pathway involving GPR39, beta-arrestin 1, and EGFR. This process requires specific phosphorylation events mediated by PDK1 and mTORC2, independent of G protein signaling.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Signaling
Background:
- Obestatin, a gut peptide from the ghrelin gene, binds to the G protein-coupled receptor GPR39.
- Understanding obestatin's intracellular signaling is crucial for elucidating its physiological roles.
Purpose of the Study:
- To characterize the transmembrane signaling pathway of obestatin.
- To identify the intracellular mechanisms responsible for Akt activation by obestatin.
Main Methods:
- Sequential analysis of obestatin's transmembrane signaling pathway.
- Investigated Akt activation through phosphorylation site analysis (T308, S473).
- Examined the roles of G protein subunits, beta-arrestin 1, Src, and EGFR.
Main Results:
- Akt activation requires T308 phosphorylation by phosphoinositide-dependent kinase 1 (PDK1) and S473 phosphorylation by mTOR kinase complex 2 (mTORC2).
- Obestatin triggers GPR39/beta-arrestin 1/Src complex formation, leading to epidermal growth factor receptor (EGFR) transactivation.
- Obestatin administration increased phosphorylation of mTOR and p70S6K1, paralleling Akt activation.
Conclusions:
- A novel signaling pathway for obestatin-mediated Akt activation is proposed, involving beta-arrestin 1 scaffolding and EGFR transactivation.
- This pathway is independent of G(i/o)-protein and Gbetagamma dimers.
- Elucidates key molecular events in obestatin signaling.
Related Concept Videos
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

